Guidelines on Design and Protocol of Drug Real-world Evidence Study (Trial)
Request Guidelines on Design and Protocol of Drug Real-world Evidence Study (Trial)
  • Local Title:药物真实世界研究设计与方案框架指导原则(试行)
  • Country/Region:Chinese Mainland
  • Competent Authority: Center for Drug Evaluation (CDE)
  • Type:Guideline
  • Status:In force
  • Release Date:2023-02-16
  • Implementation Date:2023-02-16
Document
Language Source Title Access
ZH Official 药物真实世界研究设计与方案框架指导原则(试行) Download
Summary

The Guidelines on Design and Protocol of Drug Real-World Evidence Study (Trial) applies to the clinical evidence aquired from real-world study for drug evaluation. 

The applicability of real-world evidence (RWE) in supporting drug R&D and regulatory decision is specified in the Guidelines for Real-world Evidence Supporting Drug R&D and Review (Trial)

The Guidelines on Design and Protocol of Drug Real-World Evidence Study (Trial) can also be a reference for real-world study that does not aim for drug registration.